Device allows scientists to control gene activity across generations of cells

Just as cells inherit genes, they also inherit a set of instructions that tell genes when to become active, in which tissues and to what extent. Now, Rockefeller University researchers have built a device that, by allowing scientists to turn genes on and off in actively multiplying budding yeast cells, will help them figure out more precisely than before how genes and proteins interact with one another and how these interactions drive cellular functions.

“A slight disturbance in the abundance of a single protein can affect the functioning of a cell dramatically,” says Gilles Charvin, a postdoc who works with both Eric Siggia, head of the Laboratory of Theoretical Condensed Matter Physics, and Frederick Cross, head of the Laboratory of Yeast Molecular Genetics. “So, we wanted to devise a way to supply a single cell with a controlled pulse of protein at any time and then see how the cell would respond,” he says.

Although scientists have had the tools to track single cells and measure the protein levels within them, the new device allows scientists to track them for a longer period of time while not only monitoring but also controlling the activity of genes. The precision with which the device can track single cells also allows scientists to construct pedigrees, making it possible to compare gene activity from one cell to the next.

The device relies on electrovalves to control a flow of media, which travels through a tube and then diffuses across a porous membrane to reach the budding yeast cells. The cells are clamped between this membrane and a soft material, which forces them to bud horizontally without damage.

“That was the major design hurdle,”� says Charvin. “To create a device in which cells don’t move, so that you can track hundreds of single cells for a long time — about eight rounds of cell division — which typically lasts 12 hours.”�

In order to induce the activity of a gene, the researchers used inducer molecules that diffuse through the cell membrane and control DNA segments called promoters. The molecule’s presence silences the promoter, which silences the expression of the gene; the molecule’s absence, on the other hand, activates the promoter, which activates the gene to crank up the molecule’s production.

By exploiting this principle, the scientists showed that they could successfully turn specific genes on and off by controlling the flow of an inducer molecule called methionine. They observed that pulses as short as 10 minutes led to changes in protein levels that could be measured.

The group used this device to study the cell cycle by putting a gene that must be expressed for cells to divide under the control of the methionine promoter, and showed that budding yeast cells would stop and start dividing in perfect synchrony with alternating pulses of media that did and didn’t contain methionine. “Like slaves, the cells relied on the external pulse we gave them to figure out what to do next,” says Charvin. “We thought this was a pretty striking illustration of the capabilities of this device.”

Citation: Public Library of Science One 1: e1468 (January 2008)

Source: Rockefeller University

Related stories:

A Viral Cloaking Device: Biologists show how Human Cytomegalovirus hides from the immune system
(PhysOrg.com) -- Viruses achieve their definition of success when they can thrive without killing their host. Now, biologists Pamela Bjorkman and Zhiru Yang of the California Institute of Technology have uncovered how one such virus, prevalent in humans, evolved over time to hide from the immune system.
An alternative to chemotherapy: Nanoparticles tackle pediatric brain tumors
An interdisciplinary team of researchers at Washington University in St. Louis, led by Karen L. Wooley, Ph.D., James S. McDonnell Distinguished University Professor in Arts & Sciences, is a step closer to delivering cancer-killing drugs to pediatric brain tumors, similar to the tumor that Senator Ted Kennedy is suffering from.
Circulating tumor cells can reveal genetic signature of dangerous lung cancers
Massachusetts General Hospital (MGH) investigators have shown that an MGH-developed, microchip-based device that detects and analyzes tumor cells in the bloodstream can be used to determine the genetic signature of lung tumors, allowing identification of those appropriate for targeted treatment and monitoring genetic changes that occur during therapy. A pilot study of the device called the CTC-chip will appear in the July 24 New England Journal of Medicine and is receiving early online release.
Researchers coat titanium with polymer to improve integration of joint replacements
Research at the Georgia Institute of Technology shows that coating a titanium implant with a new biologically inspired material enhances tissue healing, improves bone growth around the implant and strengthens the attachment and integration of the implant to the bone.
Novel memory device is set to rival transistor-switched silicon-based memory
Working with an international group of researchers, Professor Gehan Amaratunga has produced a novel memory device which is set to rival transistor-switched silicon-based memory.
NIST/NIH micromagnets show promise as colorful 'smart tags' for magnetic resonance imaging
Colo.-Customized microscopic magnets that might one day be injected into the body could add color to magnetic resonance imaging (MRI), while also potentially enhancing sensitivity and the amount of information provided by images, researchers at the National Institute of Standards and Technology (NIST) and National Institutes of Health (NIH) report. The new micromagnets also could act as "smart tags" identifying particular cells, tissues, or physiological conditions, for medical research or diagnostic purposes.
'Nanoglassblowing' Seen as Boon to Study of Individual Molecules
While the results may not rival the artistry of glassblowers in Europe and Latin America, researchers at the National Institute of Standards and Technology and Cornell University have found beauty in a new fabrication technique called “nanoglassblowing” that creates nanoscale (billionth of a meter) fluidic devices used to isolate and study single molecules in solution—including individual DNA strands. The novel method is described in a paper posted online this week in the journal Nanotechnology.
Fireflies' glow helps researchers track cancer drug's effectiveness
The gene that allows fireflies to flash is helping researchers track the effectiveness of anti-cancer drugs over time.

News discussion:

General Science news